Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
Mechanism of Action | Multikinase Inhibitors
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
Sorafenib Pharmacodynamics
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. - Abstract - Europe PMC
Sorafenib (NEXAVAR)®
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Mechanism of Action | NEXAVAR® (sorafenib) Global HCP Website
Sorafenib - Mechanism of Action in treating Advanced Hepatocellular Carcinoma
Potential mechanisms of action of Sorafenib in RCC. Note: Sorafenib can... | Download Scientific Diagram
Mechanisms of sorafenib resistance. Sorafenib as an anticancer drug is... | Download Scientific Diagram
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine
IJMS | Free Full-Text | Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment | HTML
Systemic Therapies in Hepatocellular Carcinoma
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Sorafenib - Wikipedia
Figure 1 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
